-
EP3957634
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3957634
| EP3957634 - CRYSTAL FORM OF SGLT INHIBITOR AND APPLICATION THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 21.01.2022 Database last updated on 10.07.2024 | |
| Former | The international publication has been made Status updated on 18.01.2021 | Most recent event Tooltip | 02.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Shangdong Danhong Pharmaceutical Co., Ltd. No.99, Kunming Road Mudan Industrial Park District Heze Shangdong 274000 / CN | [2022/08] | Inventor(s) | 01 /
MAO, Qinghua 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | 02 /
YU, Tao 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | 03 /
LI, Yi 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | 04 /
WU, Chengde 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | 05 /
YAO, Ting 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | [2022/08] | Representative(s) | Groth & Co. KB P.O. Box 6107 102 32 Stockholm / SE | [2022/08] | Application number, filing date | 20836320.0 | 03.07.2020 | [2022/08] | WO2020CN100072 | Priority number, date | CN201910604504 | 05.07.2019 Original published format: CN201910604504 | [2022/08] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021004388 | Date: | 14.01.2021 | Language: | ZH | [2021/02] | Type: | A1 Application with search report | No.: | EP3957634 | Date: | 23.02.2022 | Language: | EN | [2022/08] | Search report(s) | International search report - published on: | CN | 14.01.2021 | (Supplementary) European search report - dispatched on: | EP | 01.08.2022 | Classification | IPC: | C07D407/10, C07H1/00, A61P3/10 | [2022/08] | CPC: |
A61P3/10 (EP,KR);
C07H7/04 (EP,KR,US);
A61K31/7034 (KR);
C07D309/10 (EP);
C07H1/00 (EP,KR,US);
C07H1/06 (US);
C07B2200/13 (KR,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/08] | Title | German: | SGLT-INHIBITOR IN KRISTALLFORM UND SEINE VERWENDUNG | [2022/08] | English: | CRYSTAL FORM OF SGLT INHIBITOR AND APPLICATION THEREOF | [2022/08] | French: | FORME CRISTALLINE D'INHIBITEUR DE SGLT ET SON APPLICATION | [2022/08] | Entry into regional phase | 17.11.2021 | Translation filed | 17.11.2021 | National basic fee paid | 17.11.2021 | Search fee paid | 17.11.2021 | Designation fee(s) paid | 17.11.2021 | Examination fee paid | Examination procedure | 17.11.2021 | Examination requested [2022/08] | 08.12.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 22.06.2022 | Renewal fee patent year 03 | 23.06.2023 | Renewal fee patent year 04 | 01.07.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AD]EP3466958 (CRYSTAL PHARMACEUTICAL SUZHOU CO LTD [CN]) [AD] 1-15* claim - * |